That wound healing might be impaired by penicillamine is suggested by the animal studies of Harkness (1968) ; however, the dosage employed was considerably in excess of that current in therapeutics. Using skin biopsies from patients with seropositive rheumatoid arthritis before and after some months of penicillamine therapy, Francis & Mowat (1974) showed that the total collagen tended to decrease with penicillamine therapy and that the maturation of such collagen was impaired. Harvey et al. (1974) have also suggested that penicillamine could cause thinning of the skin. Against this background it is not surprizing that at various meetings occasional reports on the failure of wound healing have been recorded. Thus Duthie (1974) drew attention to this in a patient undergoing an arthrodesis of the knee, while Burry (1974) reported a rheumatoid patient on treatment with penicillamine who had a spontaneous pneumothorax which had been associated with considerable problems in wound healing.
Elective surgery of many types is now regarded as an integral part of the management of rheumatoid arthritis. It was therefore, decided to look at wound healing in our patients who were undergoing elective orthopedic surgery and who were on or had received penicillamine therapy for a minimum period of six months at the time of surgery. Our standard proforma included not only penicillamine therapy with dosage and duration, but also whether the patients were on corticosteroids and, if so, if they had any suggestion of Cushing's syndrome, as well as what was felt to be important in deciding whether a wound had healed satisfactorily. Needless to say, the nature of the orthopedic procedure was also recorded.
In the first pilot study 20 patients with adult or juvenile arthritis were reviewed. In 10 the penicillamine was withdrawn one week before surgery and discontinued for the first five weeks after surgery, while in the other 10 the penicillamine continued throughout. One patient on both prednisone and penicillamine exhibited delay in wound healing as did 1 patient in whom penicillamine had been withdrawn before surgery. The other 9 in each group showed normal wound healing.
After general discussion it was felt that this was not the best way to look at this problem, as the seven days' withdrawal was almost certainly too short to influence either the thickness of the skin or the maturation of the collagen, and no attention had been paid to the duration of the corticosteroid therapy. It was therefore decided that from now onwards patients on penicillamine therapy would continue receiving it during their elective surgery, and the next patient with rheumatoid arthritis or Still's disease admitted for elective surgery would act as a control.
The new proforma (Fig 1) was similar to the original but more attention was paid to previous corticosteroid therapy. The preliminary analysis of these results early in 1976 showed very little difference in that healing could be regarded as normal in 20 of the 24 procedures in patients on penicillamine and in 19 of the 24 procedures in those acting as controls. (Table 1) .
However, it was noted that in the control group, three of the five showing delay in healing had been on very prolonged corticosteroid therapy and had exhibited much spontaneous bruising for at least one year before surgery. It was also noted that two of the patients in the control group showing delayed healing had undergone total replacement knee arthroplasties while no such operation had been performed in the penicillamine group. It was therefore decided to look again at the penicillamine group with regard to their disease state, the duration of disease to surgery, the duration of prednisone therapy and the type of surgery.
First we tried to see how many could be matched in the controls we already had, and since that time we have attempted to select controls from the waiting list who matched previously-operated patients with penicillamine and, similarly, for any new patients with penicillamine we have tried to find a matched control from the waiting list. This has proved to be extraordinarily difficult as, in general, patients on penicillamine had disease of shorter duration but considerably more severity and were more frequently on prednisone. In many cases the penicillamine had been introduced to allow reduction of corticosteroid dosage. It has (Table 2) .
The penicillamine dosage has varied from 375 mg to I g daily, our overall policy h4ving been one of low dosage, and the duration of therapy has varied from six months to three years, with a mean of 1.5 years. Corticosteroid therapy in juveniles has frequently been on the alternateday pattern, and even in those adults and juveniles on daily therapy dosage has been low, never more than 7.5 mg daily. In addition to this Controls"; 12 procedures in 9 Still's disease 9 procedures in 9 RA Delayed healing 2 *9 on corticosteroids *3 on corticosteroids study group, 2 patients with rheumatoid arthritis have had to undergo emergency surgery, one for a spontaneous pneumothorax such as that described by Burry (1974) , and the other for a cholecystectomy, and both have healed normally.
Conclusions
In Still's disease and rheumatoid arthritis penicillamine, in moderate dosage of relatively short duration, does not appear seriously to interfere with wound healing. However, it would seem desirable to continue to assess patients on penicillamine, as it may well be that prolonged therapy, and particularly if associated with prolonged corticosteroid therapy, might have a deleterious effect on healing.
following haematoma and four due to separation of the wound edges.
Dr I H Scheinberg (Chairman): What was the dose of peiiicillamine? Was,it the same in all the patients ? Dr Mowaf: No, a wide range of dose was used, from 750 mg to 2 g. Dr Schenberg: Did many of the patients receive more than f g ? Dr Mowat: About half the patients.
Dr Ansell: Our wound healing was rather shorter than Dr Mowat's. Many years ago we also did a prolonged study on ourl patients. We had to subdivide them into juveniles and adults, because the mean healing time in the former was only 1 1.1 days, whereas in the adults it was 12 or more days. I do not understand why our wound healing rate is less than Dr Mowat's.
This work was done about 10 years ago when steroids were not commonly used in our unit. We were not really able to say 'three years' quite so definitely as Or Mowat. At that time we felt that probably nearer five years, at doses of about 5 mg of prednisone, was significant.
DISCUSSION

Dr A G Mowat (Oxford): May I add to Dr
Ansell's remarks about wound healing in patients with rheumatoid arthritis?
In an earlier study, using criteria very similar to those described by Dr Ansell (Garner, Mowat & Hazleman 1973 , Journal of Bone and Joint Surgery 55B, 134144), we found that the mean number of days to wound healing in 100 patients with rheumatoid arthritis undergoing a wide range of orthopedic surgical operations was 16.6 days, and was not significantly different from that in carefully matched subjects with degenerative arthritis, 15.2 days. No factor altered the healing rate except corticosteroid therapy when given, irrespective of dose, for more than three years, when the mean numbe'r of days to healing rose to 20.3 days.
Dr D Schorn, working in my department, has examined wound healing after 30 comparable operations in 15 patients who had received Dpenicillamine in a daily d9se of 500-1250 mg (mean 750 nig) for 4-72 months (mean 24). Six of these patients had also received corticosteroids for more than 3 years. The mean number of days to healing was 21.5 (range 14-80 days), a time comparable with the effect of longer term corticosteroid therapy. Seven wounds showed delayed healing, two following infection, one
